Brief: Fulcrum Therapeutics Announces Pricing Of Upsized $175.0 Million Public Offering Of Common Stock And Pre-Funded Warrants
10/12/2025 12:49
Dec 10 (Reuters) - Fulcrum Therapeutics Inc FULC.O: FULCRUM THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $175.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS FULCRUM THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 11.85 MILLION SHARES AT $13.50 FULCRUM THERAPEUTICS INC - UNDERWRITERS GRANTED OPTION FOR 1.94 MILLION ADDITIONAL SHARES Source text: ID:nGNX8XtPcN Further company coverage: FULC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program